This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This ADAM11 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-228 amino acids from the N-terminal region of human ADAM11.
ADAM11
Reaktivität: Human, Maus
WB, IF (cc), IF (p)
Wirt: Kaninchen
Polyclonal
Cy5
Applikationshinweise
For WB starting dilution is: 1:500
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
DKFZp459F101 antikoerper, AW060611 antikoerper, Mdc antikoerper, MDC antikoerper, mdc antikoerper, mdc11a antikoerper, xMDC11 antikoerper, ADAM metallopeptidase domain 11 antikoerper, a disintegrin and metallopeptidase domain 11 antikoerper, ADAM metallopeptidase domain 11 L homeolog antikoerper, ADAM11 antikoerper, adam11 antikoerper, Adam11 antikoerper, adam11.L antikoerper
Hintergrund
This gene encodes a member of the ADAM (a disintegrin and metalloprotease) protein family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This gene represents a candidate tumor supressor gene for human breast cancer based on its location within a minimal region of chromosome 17q21 previously defined by tumor deletion mapping. [provided by RefSeq].